Blood Substitute update: HemoBioTech, Inc. Chairman and CEO Dr. Arthur Bollon to Give Presentation Tomorrow, August 14th, About the Development of HemoBioTech, Inc., at the “FFN & WSR Small Cap Conference” in New York City

DALLAS--(BUSINESS WIRE)--HemoBioTech (OTCBB: HMBT.OB) announced that its Chairman and CEO, Arthur Bollon, Ph.D., will give a presentation tomorrow, Tuesday, August 14, 2007, during the “Flaherty Financial News & WallStreet Research Small Cap Conference” to be held at The Penn Club of New York, Tarnopol Room, 10th Floor, 30 West 44th Street, New York City. To register online, please visit http://smallcapconference.org/registration.html.